Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma As a result of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results